ID   GAL4_YEAST              Reviewed;         881 AA.
AC   P04386; D6W3C3;
DT   20-MAR-1987, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 2.
DT   22-JUL-2015, entry version 161.
DE   RecName: Full=Regulatory protein GAL4;
GN   Name=GAL4; OrderedLocusNames=YPL248C;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6366516;
RA   Laughon A., Gesteland R.F.;
RT   "Primary structure of the Saccharomyces cerevisiae GAL4 gene.";
RL   Mol. Cell. Biol. 4:260-267(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169875;
RA   Bussey H., Storms R.K., Ahmed A., Albermann K., Allen E., Ansorge W.,
RA   Araujo R., Aparicio A., Barrell B.G., Badcock K., Benes V.,
RA   Botstein D., Bowman S., Brueckner M., Carpenter J., Cherry J.M.,
RA   Chung E., Churcher C.M., Coster F., Davis K., Davis R.W.,
RA   Dietrich F.S., Delius H., DiPaolo T., Dubois E., Duesterhoeft A.,
RA   Duncan M., Floeth M., Fortin N., Friesen J.D., Fritz C., Goffeau A.,
RA   Hall J., Hebling U., Heumann K., Hilbert H., Hillier L.W.,
RA   Hunicke-Smith S., Hyman R.W., Johnston M., Kalman S., Kleine K.,
RA   Komp C., Kurdi O., Lashkari D., Lew H., Lin A., Lin D., Louis E.J.,
RA   Marathe R., Messenguy F., Mewes H.-W., Mirtipati S., Moestl D.,
RA   Mueller-Auer S., Namath A., Nentwich U., Oefner P., Pearson D.,
RA   Petel F.X., Pohl T.M., Purnelle B., Rajandream M.A., Rechmann S.,
RA   Rieger M., Riles L., Roberts D., Schaefer M., Scharfe M., Scherens B.,
RA   Schramm S., Schroeder M., Sdicu A.-M., Tettelin H., Urrestarazu L.A.,
RA   Ushinsky S., Vierendeels F., Vissers S., Voss H., Walsh S.V.,
RA   Wambutt R., Wang Y., Wedler E., Wedler H., Winnett E., Zhong W.-W.,
RA   Zollner A., Vo D.H., Hani J.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XVI.";
RL   Nature 387:103-105(1997).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   MUTAGENESIS, AND ZINC REQUIREMENT.
RX   PubMed=3299106; DOI=10.1038/328353a0;
RA   Johnston M.;
RT   "Genetic evidence that zinc is an essential co-factor in the DNA
RT   binding domain of GAL4 protein.";
RL   Nature 328:353-355(1987).
RN   [5]
RP   INTERACTION WITH SRB4.
RX   PubMed=9660972; DOI=10.1016/S1097-2765(00)80088-X;
RA   Koh S.S., Ansari A.Z., Ptashne M., Young R.A.;
RT   "An activator target in the RNA polymerase II holoenzyme.";
RL   Mol. Cell 1:895-904(1998).
RN   [6]
RP   INTERACTION WITH GAL11.
RX   PubMed=11478912; DOI=10.1021/bi010011k;
RA   Jeong C.-J., Yang S.-H., Xie Y., Zhang L., Johnston S.A., Kodadek T.;
RT   "Evidence that Gal11 protein is a target of the Gal4 activation domain
RT   in the mediator.";
RL   Biochemistry 40:9421-9427(2001).
RN   [7]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A.,
RA   Dephoure N., O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [8]
RP   DOMAIN.
RX   PubMed=17467953; DOI=10.1016/j.ygeno.2007.02.003;
RA   Piskacek S., Gregor M., Nemethova M., Grabner M., Kovarik P.,
RA   Piskacek M.;
RT   "Nine-amino-acid transactivation domain: establishment and prediction
RT   utilities.";
RL   Genomics 89:756-768(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-712, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.M700468-MCP200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth
RT   phosphoproteome analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-694; SER-696; SER-699
RP   AND SER-703, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19779198; DOI=10.1126/science.1172867;
RA   Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.;
RT   "Global analysis of Cdk1 substrate phosphorylation sites provides
RT   insights into evolution.";
RL   Science 325:1682-1686(2009).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 1-65.
RX   PubMed=1557122; DOI=10.1038/356408a0;
RA   Marmorstein R., Carey M., Ptashne M., Harrison S.C.;
RT   "DNA recognition by GAL4: structure of a protein-DNA complex.";
RL   Nature 356:408-414(1992).
RN   [12]
RP   STRUCTURE BY NMR OF ZINC-BINDING REGION.
RX   PubMed=2107541; DOI=10.1073/pnas.87.6.2077;
RA   Pan T., Coleman J.E.;
RT   "GAL4 transcription factor is not a 'zinc finger' but forms a
RT   Zn(II)2Cys6 binuclear cluster.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:2077-2081(1990).
RN   [13]
RP   STRUCTURE BY NMR OF ZINC-BINDING REGION.
RX   PubMed=2021614; DOI=10.1021/bi00231a016;
RA   Pan T., Coleman J.E.;
RT   "Sequential assignments of the 1H NMR resonances of Zn(II)2 and
RT   113Cd(II)2 derivatives of the DNA-binding domain of the GAL4
RT   transcription factor reveal a novel structural motif for specific DNA
RT   recognition.";
RL   Biochemistry 30:4212-4222(1991).
RN   [14]
RP   STRUCTURE BY NMR OF ZINC-BINDING REGION.
RX   PubMed=2265711; DOI=10.1016/0014-5793(90)80504-C;
RA   Gadhavi P.L., Raine A.R.C., Alefounder P.R., Laue E.D.;
RT   "Complete assignment of the 1H NMR spectrum and secondary structure of
RT   the DNA binding domain of GAL4.";
RL   FEBS Lett. 276:49-53(1990).
RN   [15]
RP   STRUCTURE BY NMR OF ZINC-BINDING REGION.
RX   PubMed=1557129; DOI=10.1038/356448a0;
RA   Kraulis P.J., Raine A.R.C., Gadhavi P.L., Laue E.D.;
RT   "Structure of the DNA-binding domain of zinc GAL4.";
RL   Nature 356:448-450(1992).
RN   [16]
RP   STRUCTURE BY NMR OF ZINC-BINDING REGION.
RX   PubMed=1557130; DOI=10.1038/356450a0;
RA   Baleja J.D., Marmorstein R., Harrison S.C., Wagner G.;
RT   "Solution structure of the DNA-binding domain of Cd2-GAL4 from S.
RT   cerevisiae.";
RL   Nature 356:450-453(1992).
CC   -!- FUNCTION: This protein is a positive regulator for the gene
CC       expression of the galactose-induced genes such as GAL1, GAL2,
CC       GAL7, GAL10, and MEL1 which code for the enzymes used to convert
CC       galactose to glucose. It recognizes a 17 base pair sequence in
CC       (5'-CGGRNNRCYNYNCNCCG-3') the upstream activating sequence (UAS-G)
CC       of these genes.
CC   -!- SUBUNIT: Binds DNA as a homodimer. Interacts directly with the
CC       mediator subunits GAL11/MED15 and SRB4/MED17.
CC       {ECO:0000269|PubMed:11478912, ECO:0000269|PubMed:9660972}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DOMAIN: the 9aaTAD motif (residues 862 to 870) is a
CC       transactivation domain present in a large number of yeast and
CC       animal transcription factors. {ECO:0000269|PubMed:17467953}.
CC   -!- PTM: Association between GAL11 and GAL4 may serve to expedite
CC       phosphorylation of GAL4.
CC   -!- MISCELLANEOUS: Present with 166 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Contains 1 Zn(2)-C6 fungal-type DNA-binding domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00227}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; K01486; AAA34626.1; -; Genomic_DNA.
DR   EMBL; Z67751; CAA91596.1; -; Genomic_DNA.
DR   EMBL; Z73604; CAA97969.1; -; Genomic_DNA.
DR   EMBL; BK006949; DAA11189.1; -; Genomic_DNA.
DR   PIR; A05022; RGBYG4.
DR   RefSeq; NP_015076.1; NM_001184062.1.
DR   PDB; 1AW6; NMR; -; A=1-43.
DR   PDB; 1D66; X-ray; 2.70 A; A/B=1-65.
DR   PDB; 1HBW; NMR; -; A/B=50-106.
DR   PDB; 3BTS; X-ray; 2.70 A; E/F=854-874.
DR   PDB; 3COQ; X-ray; 2.40 A; A/B=8-96.
DR   PDBsum; 1AW6; -.
DR   PDBsum; 1D66; -.
DR   PDBsum; 1HBW; -.
DR   PDBsum; 3BTS; -.
DR   PDBsum; 3COQ; -.
DR   ProteinModelPortal; P04386; -.
DR   SMR; P04386; 8-96.
DR   BioGrid; 35915; 87.
DR   DIP; DIP-593N; -.
DR   IntAct; P04386; 5.
DR   MINT; MINT-1510289; -.
DR   PaxDb; P04386; -.
DR   PeptideAtlas; P04386; -.
DR   EnsemblFungi; YPL248C; YPL248C; YPL248C.
DR   GeneID; 855828; -.
DR   KEGG; sce:YPL248C; -.
DR   CYGD; YPL248c; -.
DR   EuPathDB; FungiDB:YPL248C; -.
DR   SGD; S000006169; GAL4.
DR   eggNOG; NOG85363; -.
DR   HOGENOM; HOG000112689; -.
DR   InParanoid; P04386; -.
DR   KO; K09241; -.
DR   OMA; FRYILWE; -.
DR   OrthoDB; EOG7J44JV; -.
DR   BioCyc; YEAST:G3O-34134-MONOMER; -.
DR   EvolutionaryTrace; P04386; -.
DR   NextBio; 980383; -.
DR   PRO; PR:P04386; -.
DR   Proteomes; UP000002311; Chromosome XVI.
DR   GO; GO:0005634; C:nucleus; IDA:SGD.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:SGD.
DR   GO; GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:SGD.
DR   GO; GO:0001085; F:RNA polymerase II transcription factor binding; IDA:SGD.
DR   GO; GO:0001133; F:sequence-specific transcription regulatory region DNA binding RNA polymerase II transcription factor recruiting transcription factor activity; IMP:SGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006012; P:galactose metabolic process; IMP:SGD.
DR   GO; GO:0000435; P:positive regulation of transcription from RNA polymerase II promoter by galactose; IDA:SGD.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; IDA:GOC.
DR   Gene3D; 4.10.240.10; -; 1.
DR   InterPro; IPR005600; Gal4_dimer_dom.
DR   InterPro; IPR007219; Transcription_factor_dom_fun.
DR   InterPro; IPR001138; Zn2-C6_fun-type_DNA-bd.
DR   Pfam; PF04082; Fungal_trans; 1.
DR   Pfam; PF03902; Gal4_dimer; 1.
DR   Pfam; PF00172; Zn_clus; 1.
DR   SMART; SM00906; Fungal_trans; 1.
DR   SMART; SM00066; GAL4; 1.
DR   SUPFAM; SSF57701; SSF57701; 1.
DR   PROSITE; PS00463; ZN2_CY6_FUNGAL_1; 1.
DR   PROSITE; PS50048; ZN2_CY6_FUNGAL_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Carbohydrate metabolism; Complete proteome;
KW   DNA-binding; Galactose metabolism; Metal-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation; Zinc.
FT   CHAIN         1    881       Regulatory protein GAL4.
FT                                /FTId=PRO_0000114951.
FT   DNA_BIND     11     38       Zn(2)-C6 fungal-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00227}.
FT   MOTIF       862    870       9aaTAD.
FT   METAL        11     11       Zinc 1.
FT   METAL        11     11       Zinc 2.
FT   METAL        14     14       Zinc 1.
FT   METAL        21     21       Zinc 1.
FT   METAL        28     28       Zinc 1.
FT   METAL        28     28       Zinc 2.
FT   METAL        31     31       Zinc 2.
FT   METAL        38     38       Zinc 2.
FT   MOD_RES     694    694       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:19779198}.
FT   MOD_RES     696    696       Phosphoserine.
FT                                {ECO:0000269|PubMed:19779198}.
FT   MOD_RES     699    699       Phosphoserine.
FT                                {ECO:0000269|PubMed:19779198}.
FT   MOD_RES     703    703       Phosphoserine.
FT                                {ECO:0000269|PubMed:19779198}.
FT   MOD_RES     712    712       Phosphoserine.
FT                                {ECO:0000269|PubMed:18407956}.
FT   MUTAGEN      26     26       P->L: Loss of DNA-binding.
FT                                {ECO:0000269|PubMed:3299106}.
FT   HELIX        12     17       {ECO:0000244|PDB:3COQ}.
FT   STRAND       25     27       {ECO:0000244|PDB:3COQ}.
FT   HELIX        29     33       {ECO:0000244|PDB:3COQ}.
FT   HELIX        51     71       {ECO:0000244|PDB:3COQ}.
FT   STRAND       73     75       {ECO:0000244|PDB:3COQ}.
FT   HELIX        77     82       {ECO:0000244|PDB:3COQ}.
FT   HELIX        86     93       {ECO:0000244|PDB:3COQ}.
SQ   SEQUENCE   881 AA;  99403 MW;  29D7FF68B0B05880 CRC64;
     MKLLSSIEQA CDICRLKKLK CSKEKPKCAK CLKNNWECRY SPKTKRSPLT RAHLTEVESR
     LERLEQLFLL IFPREDLDMI LKMDSLQDIK ALLTGLFVQD NVNKDAVTDR LASVETDMPL
     TLRQHRISAT SSSEESSNKG QRQLTVSIDS AAHHDNSTIP LDFMPRDALH GFDWSEEDDM
     SDGLPFLKTD PNNNGFFGDG SLLCILRSIG FKPENYTNSN VNRLPTMITD RYTLASRSTT
     SRLLQSYLNN FHPYCPIVHS PTLMMLYNNQ IEIASKDQWQ ILFNCILAIG AWCIEGESTD
     IDVFYYQNAK SHLTSKVFES GSIILVTALH LLSRYTQWRQ KTNTSYNFHS FSIRMAISLG
     LNRDLPSSFS DSSILEQRRR IWWSVYSWEI QLSLLYGRSI QLSQNTISFP SSVDDVQRTT
     TGPTIYHGII ETARLLQVFT KIYELDKTVT AEKSPICAKK CLMICNEIEE VSRQAPKFLQ
     MDISTTALTN LLKEHPWLSF TRFELKWKQL SLIIYVLRDF FTNFTQKKSQ LEQDQNDHQS
     YEVKRCSIML SDAAQRTVMS VSSYMDNHNV TPYFAWNCSY YLFNAVLVPI KTLLSNSKSN
     AENNETAQLL QQINTVLMLL KKLATFKIQT CEKYIQVLEE VCAPFLLSQC AIPLPHISYN
     NSNGSAIKNI VGSATIAQYP TLPEENVNNI SVKYVSPGSV GPSPVPLKSG ASFSDLVKLL
     SNRPPSRNSP VTIPRSTPSH RSVTPFLGQQ QQLQSLVPLT PSALFGGANF NQSGNIADSS
     LSFTFTNSSN GPNLITTQTN SQALSQPIAS SNVHDNFMNN EITASKIDDG NNSKPLSPGW
     TDQTAYNAFG ITTGMFNTTT MDDVYNYLFD DEDTPPNPKK E
//
